Liver function in drug addicts: hepatitis B markers and cell-mediated immunity.
Liver function tests, hepatitis B virus (HBV) markers and cell-mediated immunity were evaluated in 100 drug addicts and in 54 healthy controls. Liver damage prevalence was much higher in the drug group, both in HBV marker-positive and in marker-negative subjects. Moreover HBV marker distribution was different among addicts in comparison with controls, in which the patterns of infection overcoming were more frequent. Cell-mediated immunity assessment showed a deep depression in the addict group. These data suggest that liver damage in addicts may be due mainly to the immunologic defect, which would have a negative influence on the action of HBV and of other viral and non-viral agents.